Does IMATINIB Cause Dermatofibrosarcoma protuberans? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Dermatofibrosarcoma protuberans have been filed in association with IMATINIB (Imatinib). This represents 0.0% of all adverse event reports for IMATINIB.
12
Reports of Dermatofibrosarcoma protuberans with IMATINIB
0.0%
of all IMATINIB reports
7
Deaths
2
Hospitalizations
How Dangerous Is Dermatofibrosarcoma protuberans From IMATINIB?
Of the 12 reports, 7 (58.3%) resulted in death, 2 (16.7%) required hospitalization.
Is Dermatofibrosarcoma protuberans Listed in the Official Label?
Yes, Dermatofibrosarcoma protuberans is listed as a known adverse reaction in the official FDA drug label for IMATINIB.
What Other Side Effects Does IMATINIB Cause?
Death (9,708)
Drug ineffective (2,628)
Nausea (2,379)
Diarrhoea (2,203)
Fatigue (1,810)
Malignant neoplasm progression (1,716)
Vomiting (1,599)
Malaise (1,361)
Drug intolerance (1,354)
Drug resistance (1,293)
What Other Drugs Cause Dermatofibrosarcoma protuberans?
Which IMATINIB Alternatives Have Lower Dermatofibrosarcoma protuberans Risk?
IMATINIB vs IMBRUVICA
IMATINIB vs IMDEVIMAB
IMATINIB vs IMEGLIMIN
IMATINIB vs IMETELSTAT
IMATINIB vs IMIDAPRIL